• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肺癌的放疗与手术联合治疗]

[Combined radiotherapy and resection in carcinoma of the lung].

作者信息

Amino S, Abe K, Hwang L M, Kanesaka N, Suzuki T, Mugishima K

出版信息

Gan No Rinsho. 1986 Oct;32(13):1743-51.

PMID:3025470
Abstract

To evaluate the therapeutic effect of surgery combined with radiotherapy in lung cancer, 385 operative cases, and 308 received combined treatment, were analyzed. The 5-year survival rate of T3 cases among pTNM-stage III cases undergoing surgery was 2.4% (1/42), while that of cases receiving combined radiotherapy was 18.9% (14/74), which showed some effectiveness. The 5 year survival rate of N2 (n3), operation only cases and combined treatment cases were 5.3% (2/38), and 8.9% (8/90), respectively. Long-term survival among cases of extensive mediastinal metastasis (# 1-9) confirmed the effect of combined therapy. Combined therapy effect was recognized in squamous cell carcinoma.

摘要

为评估手术联合放疗对肺癌的治疗效果,对385例手术病例进行了分析,其中308例接受了联合治疗。在接受手术的pTNM III期病例中,T3病例的5年生存率为2.4%(1/42),而接受联合放疗的病例为18.9%(14/74),显示出一定疗效。N2(n3)仅手术病例和联合治疗病例的5年生存率分别为5.3%(2/38)和8.9%(8/90)。广泛纵隔转移病例(#1 - 9)中的长期生存证实了联合治疗的效果。联合治疗效果在鳞状细胞癌中得到认可。

相似文献

1
[Combined radiotherapy and resection in carcinoma of the lung].[肺癌的放疗与手术联合治疗]
Gan No Rinsho. 1986 Oct;32(13):1743-51.
2
[Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].[上沟非小细胞肺癌的手术治疗:术前与术后联合放疗方案的结果]
Zentralbl Chir. 2004 Aug;129(4):270-5. doi: 10.1055/s-2004-822831.
3
[Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].[非小细胞肺癌伴(N2)纵隔淋巴结转移的外科治疗策略]
Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):62-4.
4
[Influence of preoperative radiotherapy on resection rate and long-term efficacy for patients with stage II and III lung carcinomas].[术前放疗对Ⅱ、Ⅲ期肺癌患者切除率及长期疗效的影响]
Ai Zheng. 2002 May;21(5):514-7.
5
[Surgical therapeutic planning for non-small cell lung cancer].[非小细胞肺癌的外科治疗规划]
Gan To Kagaku Ryoho. 1985 Jan;12(1):36-44.
6
Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.跳跃式纵隔淋巴结转移与肺癌:一个预后较好的特殊N2亚组。
Ann Thorac Surg. 2005 Jan;79(1):225-33. doi: 10.1016/j.athoracsur.2004.06.081.
7
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.非小细胞肺癌根治性放疗(>59 Gy)及同步化疗后的肺切除术
Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. doi: 10.1016/j.athoracsur.2004.04.085.
8
The present status of surgery for lung cancer.肺癌手术的现状
Acta Chir Belg. 1996 Nov-Dec;96(6):245-51.
9
Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?非小细胞肺癌放化疗后肺切除术:“手术侧”真的重要吗?
Ann Thorac Surg. 2009 Sep;88(3):937-43; discussion 944. doi: 10.1016/j.athoracsur.2009.04.102.
10
[Radiotherapy and integrated treatment in carcinoma of the lung].[肺癌的放射治疗与综合治疗]
Minerva Med. 1988 Apr;79(4):275-9.